无发作癫痫患者撤药后发作复发与长期结局的个体化预测模型
该系统综述与个体参与者数据荟萃分析纳入45项研究共7082例患者,其中10项研究1769例患者进入荟萃分析。研究识别了复发与长期发作的独立预测因素,并构建了列线图及网络工具用于个体化预测。
要点
- 撤药后复发率46%,9%患者末次随访年仍有发作。
- 复发预测因素包括癫痫病程、撤药前无发作间期、发病年龄等。
- 列线图可个体化预测复发风险与长期无发作概率。
核心结论
- 基于证据的列线图在儿童和成人群体中性能稳健,可预测撤药后复发风险与长期无发作机会。
研究设计与样本
- 纳入45项研究共7082例无发作并开始撤药的患者,其中10项研究1769例进入荟萃分析。
主要发现
- 1769例中812例(46%)复发;1455例中136例(9%)在末次随访年仍有发作。
- 复发独立预测因素:缓解前癫痫病程、撤药前无发作间期、发病年龄、热性惊厥史、缓解前发作次数、无自限性癫痫综合征、发育迟缓、撤药前EEG癫痫样异常。
- 末次随访年发作独立预测因素:缓解前癫痫病程、撤药前无发作间期、撤药前抗癫痫药物数量、女性、癫痫家族史、缓解前发作次数、局灶性发作、撤药前EEG癫痫样异常。
临床怎么用
- 列线图和网络工具可用于个体患者撤药后复发风险与长期无发作概率的预测。
局限性
- 缺乏继续抗癫痫药物治疗的对照组。
- 长期无发作缺乏统一定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People with epilepsy who became seizure-free while taking antiepileptic drugs might consider discontinuing their medication, with the possibility of increased quality of life because of the elimination of adverse events. The risk with this action, however, is seizure recurrence. The objectives of our study were to identify predictors of seizure recurrence and long-term seizure outcomes and to produce nomograms for estimation of individualised outcomes. METHODS: We did a systematic review and meta-analysis, and identified eligible articles and candidate predictors, using PubMed and Embase databases with a last update on Nov 6, 2014. Eligible articles had to report on cohorts of patients with epilepsy who were seizure-free and had started withdrawal of antiepileptic drugs; articles also had to contain information regarding seizure recurrences during and after withdrawal. We excluded surgical cohorts, reports with fewer than 30 patients, and reports on acute symptomatic seizures because these topics were beyond the scope of our objective. Risk of bias was assessed using the Quality in Prognosis Studies system. Data analysis was based on individual participant data. Survival curves and proportional hazards were computed. The strongest predictors were selected with backward selection. Models were converted to nomograms and a web-based tool to determine individual risks. FINDINGS: We identified 45 studies with 7082 patients; ten studies (22%) with 1769 patients (25%) were included in the meta-analysis. Median follow-up was 5·3 years (IQR 3·0-10·0, maximum 23 years). Prospective and retrospective studies and randomised controlled trials were included, covering non-selected and selected populations of both children and adults. Relapse occurred in 812 (46%) of 1769 patients; 136 (9%) of 1455 for whom data were available had seizures in their last year of follow-up, suggesting enduring seizure control was not regained by this timepoint. Independent predictors of seizure recurrence were epilepsy duration before remission, seizure-free interval before antiepileptic drug withdrawal, age at onset of epilepsy, history of febrile seizures, number of seizures before remission, absence of a self-limiting epilepsy syndrome, developmental delay, and epileptiform abnormality on electroencephalogram (EEG) before withdrawal. Independent predictors of seizures in the last year of follow-up were epilepsy duration before remission, seizure-free interval before antiepileptic drug withdrawal, number of antiepileptic drugs before withdrawal, female sex, family history of epilepsy, number of seizures before remission, focal seizures, and epileptiform abnormality on EEG before withdrawal. Adjusted concordance statistics were 0·65 (95% CI 0·65-0·66) for predicting seizure recurrence and 0·71 (0·70-0·71) for predicting long-term seizure freedom. Validation was stable across the individual study populations. INTERPRETATION: We present evidence-based nomograms with robust performance across populations of children and adults. The nomograms facilitate prediction of outcomes following drug withdrawal for the individual patient, including both the risk of relapse and the chance of long-term freedom from seizures. The main limitations were the absence of a control group continuing antiepileptic drug treatment and a consistent definition of long-term seizure freedom. FUNDING: Epilepsiefonds.
引用
- Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol. 2017. PMID: 28483337. doi:10.1016/S1474-4422(17)30114-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。